Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis

Biochemical Journal

Volumn 355, Issue 3, 2001, Pages 587-595

  Matarrese, Paola ^a   Testa, Ugo ^a   Cauda, Roberto ^b   Vella, Stefano ^a   Gambardella, Lucrezia ^a   Malorni, Walter ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Drug resistance; Mitochondrial membrane potential; Tumour necrosis factor

Indexed keywords

BIOLOGICAL MEMBRANES; CELLS; DISEASES; DRUG PRODUCTS; GENES; PROTEINS;

APOPTOSIS; MULTIDRUG RESISTANCE;

BIOCHEMISTRY;

ETOPOFOS; FAS ANTIGEN; GLYCOPROTEIN P; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL LINE; CELL MEMBRANE DEPOLARIZATION; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MITOCHONDRIAL MEMBRANE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; T LYMPHOBLAST;

EID: 0035340654     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/bj3550587     Document Type: Article

References (48)

1. 1 Evan, G. and Littlewood, T. (1998) A matter of life and cell death. Science 281, 1317-1321
2. 2 Isaacs, J. T. (1994) Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr. Opin. Oncol. 6, 82-89
3. 3 Phenix, B. N., Angel, J. B., Mandy, F., Kravcik, S., Parato, K., Chambers, K. A., Gallicano, K., Hawley-Foss, N., Cassol, S., Cameron, D. W. and Badley, A. D. (2000) Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res. Hum. Retroviruses 16, 559-567
4. 4 Compagni, A. and Christofori, G. (2000) Recent advances in research on multistage lumorigenesis. Br. J. Cancer 83, 1-5
5. 5 Gougeon, M. L. and Montagnier, L. (1999) Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Ann. N. Y. Acad. Sci. 887, 199-212
6. 6 Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature (London) 407, 770-776
7. 7 Schmitz, I., Walczak, H., Krammer, P. H. and Peter, M. E. (1999) Differences between CD95 type I and type II cells detected with the CD95 ligand. Cell Death and Differ. 6, 821-822
8. 8 Higgins, C. F. (1993) The multidrug-resistance P-glycoprotein. Curr. Opin. Cell. Biol. 5, 684-687
9. 9 Mansouri, A., Henle, K. J., Nagle, W. A. and Moss, A. J. (1990) Tumor cell drug resistance and its reversal. SAAS Bull. Biochem. Biotechnol. 3, 91-96
10. 10 Huisman, M. T., Smit, J. W. and Schinkel, A. H. (2000) Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors. AIDS 14, 237-242
11. 11 Leighton, J. and Schatz, G. (1995) An ABC transporter in the mitochondrial inner membrane is required for normal growth of yeast. EMBO J. 14, 188-195
12. 12 Lotem, J. and Sachs, L. (1993) Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemic cells. Cell. Growth Differ. 4, 41-47
13. 13 St. Croix, B. and Kerbel, R. S. (1997) Cell adhesion and drug resistance in cancer. Curr. Opin. Oncol. 9, 549-556
14. 14 Malorni, W., Ralnaldi, G., Tritarelli, E., Rivabene, R., Cianfriglia, M., Lehnert, M., Donelli, G., Peschle, C. and Testa, U. (1995) Tumor necrosis factor α is a powerful apoptotic inducer in lymphoid leukemic cells expressing the P-170 glycoprotein. Int. J. Cancer. 67, 238-247
15. 15 Cianfriglla, M., Willingham, M. C., Tombesi, M., Scagliotti, G. V., Frasca, G. and Ghersi, A. (1994) P-glycoprotein-epitope mapping. I. Identification of linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM.4.17 murine monoclonal antibody to human multi-drug-resistant cells. Int. J. Cancer 56, 153-160
16. 16 Hamada, H. and Tsuruo, T. (1986) Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 83, 7785-7789
17. 17 Kartner, N. and Ling, V. (1989) Multidrug resistance in cancer. Sci. Am. 160, 26-33
18. 18 Malorni, W., Rivabene, R., Santini, M. T. and Donelli, G. (1993) N-Acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett. 327, 75-78
19. 19 Cossarizza, A., Franceschl, C., Monti, D., Salvioli, S., Bellesia, E., Rivabene, R., Biondo, L., Rainaldi, G., Tinari, A. and Malorni, W. (1995) Protective effect of N-acetylcysteine in tumor necrosis factor alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell. Res. 220, 232-240
20. 20 Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G. and Franceschi, C. (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197, 40-45
21. 21 Parlato, S., Giammarloli, A. M., Logozzi, M., Lozupone, F., Matarrese, P., Luciani, F., Falchi, M., Malorni, W. and Fais, S. (2000) CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19, 5123-5134
22. 22 Penning, L. C., Schipper, R. G., Vercammen, D., Verhofstad, A. A., Denecker, T., Beyaert, R. and Vandenabeele, P. (1998) Sensitization of TNF-induced apoptosis with polyamine synthesis inhibitors in different human and murine tumor cell lines. Cytokine 10, 423-431
23. 23 Larrick, J. W. and Wright, S. C. (1990) Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 4, 3215-3223
24. 24 Mehlen, P., Kretz-Remy, C., Briolay, J., Fostan, P., Mirault, M. E. and Arrigo, A. P. (1995) Intracellular reactive oxygen species as apparent modulators of heat-shock protein 27 (HSP27) structural organization and phosphorylation in basal and tumor necrosis factor-α-treated T47D human carcinoma cells. Biochem. J. 312, 367-375
25. 25 Kaufmann, S. H. (1998) Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim. Biophys. Ada 1400, 195-211
26. 26 Walczak, H., Bouchon, A., Stahl, H. and Krammer, P. H. (2000) Tumor necrosis factor-related apoptosis-inducing capacity on Bcl-2 of Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res. 80, 3051-3057
27. 27 Nicotera, P., Leist, M. and Ferrando-May, E. (1999) Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. 66, 69-73
28. 28 Banki, K., Hutter, E., Gonchoroff, N. J. and Peri, A. (1999) Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspase in Fas signalling. J. Immunol. 162, 1466-1479
29. 29 Li, P., Dietz, R. and Von Harsdorf, R. (1999) p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18, 6027-6036
30. 30 Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y. and Reed, J. C. (2000) Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat. Cell Biol. 2, 318-325
31. 31 Kroemer, G., Zamzami, N. and Susin, S. A. (1997) Mitochondrial control of apoptosis. Immunol. Today. 18, 44-51
32. 32 Desagher, S. and Martinou, J. C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10, 369-377
33. 33 Chan, H. S., Lu, Y., Grogan, T. M., Haddad, G., Hipfner, D. R., Cole, S. P., Deeley, R. G., Ling, V. and Gallie, B. L. (1997) Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res. 57, 2325-2330
34. 34 Lucia, M., Cauda, R., Landay, A. L., Malorni, W., Donelli, G. and Ortona, L. (1995) Transmembrane P-glycoprotein (Pgp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res. Hum. Retroviruses 11, 893-901
35. 35 Fojo, A. T., Ueda, K., Slamon, D. J., Gottesman, M. M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors. Proc. Natl. Acad. Sci. U.S.A. 84, 265-269
36. 36 Mithsuashi, N., MiKi, T., Senbongi, H., Yokoi, N., Yano, H., Miyazaki, M., Nakajima, N., Iwanaga, T. and Yokoyama, Y. (2000) MTABC3, a novel mitochondrial ATP-binding cassette protein involved in iron homeostasis. J. Biol. Chem. 9, 17536-17540
37. 37 Burstein, D. E., Reder, I., Weiser, K., Tong, T., Prisker, A. and Haber, R. S. (1998) GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Modern Pathol. 11, 392-396
38. 38 Cavalli, L. R. and Liang, B. C. (1998) Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat. Res. 398, 19-26
39. 39 Jia, L., Liu, K. Z., Newland, A. C., Mantsch, H. H. and Kelsey, S. M. (1999) Pgp-positive leukaemic cells have increased mtDNA but no increased rate of proliferation. Br. J. Haematol. 107, 861-869
40. 40 Jia, L., Allen, P. D., Macey, M. G., Grahn, M. F., Newland, A. C. and Kelsey, S. M. (1997) Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemic cells: a possible novel mechanism of regulating drug resistance. Br. J. Haematol. 98, 680-698
41. 41 Boultwood, J., Fidler, C., Mills, K. I., Frodsham, P. M., Kusec, R., Gaiger, A., Gale, R. E., Linch, D. C., Littlewood, T. J., Moss, P. A. H. and Wainscoat, J. S. (1996) Amplification of mitochondrial DNA in acute leukaemia. Br. J. Haematol, 95, 426-431
42. 42 Jla, L., Kelsey, S. M., Grahn, M. F. and Newland, A. C. (1996) Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor α-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood 87, 2401-2410
43. 43 Lyon, R. C., Cohen, J. S., Faustino, P. J., Megnin, F. and Charles, E. M. (1988) Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res. 48, 870-877
44. 44 Jia, L., Dourmashkin, R. R., Ailen, P. D., Gray, A. B., Newland, A. C. and Kelsey, S. M. (1997) Inhibition of autophagy abrogates tumor necrosis factor α induced apoptosis in human T-lymphoblastic leukaemic cells. Br. J. Haematol. 98, 673-685
45. 45 Robertson, J. D., Gogvadze, V., Zhivotovsky, B. and Orrenius, S. (2000) Distinct pathways for stimulation of cytochrome c release by etoposide. J. Biol. Chem. 275, 32438-32443
46. 46 Walczak, H. and Krammer, P. H. (2000) The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256, 58-66
47. 47 Jia, L., Macey, M. G., Yin, Y., Newland, A. C. and Kelsey, S. M. (1999) Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemic cells undergoing apoptosis. Blood 93, 2353-2359
48. 48 Ushmoroy, A., Ratter, E., Lehmann, V., Droge, W., Schirrmacher, V. and Umansky (1999) Nitric oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degeneration and cytochrome c release. Blood 93, 2342-2352